Strata skin sciences, inc. SSKN.US Overview
SSKN AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
SSKN Current Performance
0.85%
Strata skin sciences, inc.
-1.83%
Avg of Sector
-0.40%
S&P500
SSKN Key Information
SSKN Revenue by Segments
Browsing restrictions can be lifted for a fee.
SSKN Net Income
Browsing restrictions can be lifted for a fee.
SSKN Cash Flow
Browsing restrictions can be lifted for a fee.
SSKN Profit Margin
Browsing restrictions can be lifted for a fee.
SSKN PE Ratio River
Browsing restrictions can be lifted for a fee.
SSKN Financial Forecast
Browsing restrictions can be lifted for a fee.
SSKN Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
SSKN Profile
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Price of SSKN
SSKN FAQ
When is SSKN's latest earnings report released?
The most recent financial report for Strata skin sciences, inc. (SSKN) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating SSKN's short-term business performance and financial health. For the latest updates on SSKN's earnings releases, visit this page regularly.
What is the operating profit of SSKN?
According to the latest financial report, Strata skin sciences, inc. (SSKN) reported an Operating Profit of -2.02M with an Operating Margin of -29.58% this period, representing a growth of 30.25% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is SSKN's revenue growth?
In the latest financial report, Strata skin sciences, inc. (SSKN) announced revenue of 6.81M, with a Year-Over-Year growth rate of 0.86%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does SSKN have?
As of the end of the reporting period, Strata skin sciences, inc. (SSKN) had total debt of 16.4M, with a debt ratio of 0.48. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does SSKN have?
At the end of the period, Strata skin sciences, inc. (SSKN) held Total Cash and Cash Equivalents of 7.85M, accounting for 0.23 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does SSKN go with three margins increasing?
In the latest report, Strata skin sciences, inc. (SSKN) did not achieve the “three margins increasing” benchmark, with a gross margin of 53.5%%, operating margin of -29.58%%, and net margin of -35.7%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess SSKN's profit trajectory and future growth potential.
Is SSKN's EPS continuing to grow?
According to the past four quarterly reports, Strata skin sciences, inc. (SSKN)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.58. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of SSKN?
Strata skin sciences, inc. (SSKN)'s Free Cash Flow (FCF) for the period is -749K, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 51.01% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.